NEW YORK, Nov. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Market Source Research released its latest key findings for all current investors, traders, and shareholders of StarTek, Inc.
(NYSE:SRT), Plantronics, Inc. (NYSE:PLT), Akoustis Technologies, Inc. (NASDAQ:AKTS), Genie Energy Ltd. (NYSE:GNE), Recro Pharma,
Inc. (NASDAQ:REPH), and BIO-key International Inc. (NASDAQ:BKYI), including updated fundamental summaries, consolidated fiscal
reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
SRT DOWNLOAD: http://MarketSourceResearch.com/register/?so=SRT
PLT DOWNLOAD: http://MarketSourceResearch.com/register/?so=PLT
AKTS DOWNLOAD: http://MarketSourceResearch.com/register/?so=AKTS
GNE DOWNLOAD: http://MarketSourceResearch.com/register/?so=GNE
REPH DOWNLOAD: http://MarketSourceResearch.com/register/?so=REPH
BKYI DOWNLOAD: http://MarketSourceResearch.com/register/?so=BKYI
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine
StarTek, Inc. (NYSE:SRT), Plantronics, Inc. (NYSE:PLT), Akoustis Technologies, Inc. (NASDAQ:AKTS), Genie Energy Ltd. (NYSE:GNE),
Recro Pharma, Inc. (NASDAQ:REPH), and BIO-key International Inc. (NASDAQ:BKYI) on a fundamental level and outlines the overall
demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and
overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed November 14th,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
STARTEK, INC. (SRT) REPORT OVERVIEW
StarTek's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, StarTek reported revenue of $151.51MM
vs $119.82MM (up 26.45%) and analysts estimated basic earnings per share -$0.32 vs $0.11. For the twelve months ended December
31st, 2017 vs December 31st, 2016, StarTek reported revenue of $292.60MM vs $307.20MM (down 4.75%) and analysts estimated basic
earnings per share -$0.08 vs $0.03. Analysts expect earnings to be released on March 21st, 2019. The report will be for the fiscal
period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.15. The estimated EPS forecast for the
next fiscal year is $0.25 and is expected to report on March 21st, 2019.
To read the full StarTek, Inc. (SRT) report, download it here: http://MarketSourceResearch.com/register/?so=SRT
-----------------------------------------
PLANTRONICS, INC. (PLT) REPORT OVERVIEW
Plantronics' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Plantronics reported revenue of
$483.07MM vs $210.30MM (up 129.70%) and analysts estimated basic earnings per share -$2.21 vs $0.59. For the twelve months ended
March 31st, 2018 vs March 31st, 2017, Plantronics reported revenue of $856.90MM vs $881.18MM (down 2.75%) and analysts estimated
basic earnings per share -$0.03 vs $2.56. Analysts expect earnings to be released on January 29th, 2019. The report will be for the
fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.77.
To read the full Plantronics, Inc. (PLT) report, download it here: http://MarketSourceResearch.com/register/?so=PLT
-----------------------------------------
AKOUSTIS TECHNOLOGIES, INC. (AKTS) REPORT OVERVIEW
Akoustis Technologies' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Akoustis Technologies reported revenue
of $0.31MM vs $0.30MM (up 4.02%) and analysts estimated basic earnings per share -$0.33 vs -$0.24. For the twelve months ended June
30th, 2018 vs June 30th, 2017, Akoustis Technologies reported revenue of $1.21MM vs $0.49MM (up 148.28%) and analysts estimated
basic earnings per share -$1.04 vs -$0.58. Analysts expect earnings to be released on February 1st, 2019. The report will be for
the fiscal period ending December 31st, 2018.
To read the full Akoustis Technologies, Inc. (AKTS) report, download it here: http://MarketSourceResearch.com/register/?so=AKTS
-----------------------------------------
GENIE ENERGY LTD. (GNE) REPORT OVERVIEW
Genie Energy's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Genie Energy reported revenue of
$71.84MM vs $69.47MM (up 3.41%) and basic earnings per share $0.21 vs $0.02 (up 950.00%). For the twelve months ended December
31st, 2017 vs December 31st, 2016, Genie Energy reported revenue of $264.20MM vs $212.11MM (up 24.56%) and analysts estimated basic
earnings per share -$0.36 vs -$1.14. Analysts expect earnings to be released on March 14th, 2019. The report will be for the fiscal
period ending December 31st, 2018.
To read the full Genie Energy Ltd. (GNE) report, download it here: http://MarketSourceResearch.com/register/?so=GNE
-----------------------------------------
RECRO PHARMA, INC. (REPH) REPORT OVERVIEW
Recro Pharma's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Recro Pharma reported revenue of
$18.28MM vs $17.11MM (up 6.83%) and analysts estimated basic earnings per share -$0.64 vs -$0.48. For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Recro Pharma reported revenue of $71.83MM vs $69.34MM (up 3.60%) and analysts estimated
basic earnings per share -$2.63 vs -$2.82. Analysts expect earnings to be released on February 26th, 2019. The report will be for
the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.63. The estimated EPS
forecast for the next fiscal year is -$2.82 and is expected to report on February 26th, 2019.
To read the full Recro Pharma, Inc. (REPH) report, download it here: http://MarketSourceResearch.com/register/?so=REPH
-----------------------------------------
BIO-KEY INTERNATIONAL INC. (BKYI) REPORT OVERVIEW
BIO-key International's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, BIO-key International reported revenue of $0.75MM
vs $0.89MM (down 15.65%) and analysts estimated basic earnings per share -$0.15 vs -$0.32. For the twelve months ended December
31st, 2017 vs December 31st, 2016, BIO-key International reported revenue of $6.30MM vs $2.98MM (up 111.81%) and analysts estimated
basic earnings per share -$0.76 vs -$0.89. Analysts expect earnings to be released on April 4th, 2019. The report will be for the
fiscal period ending December 31st, 2018.
To read the full BIO-key International Inc. (BKYI) report, download it here: http://MarketSourceResearch.com/register/?so=BKYI
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers,
professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team
is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA®
BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source
Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on
individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well
as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside
audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by
E-mail at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source
Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that
result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness
of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated
for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial
advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration.
For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com
© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
